Zenner J. Patrick's Insider Trades & SAST Disclosures
Zenner J. Patrick's most recent trade in Cartesian Therapeutics Inc was a trade of 7,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Zenner J. Patrick.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics Inc | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,600 | 10,374 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Zenner J. Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 228,000 | 228,000 | - | - | Stock Option (Right to Buy) | |
| Selecta Biosciences Inc | Zenner Patrick J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 178,000 | 233,248 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 49 | 10,928 | - | - | Phantom Stock Unit | |
| Selecta Biosciences Inc | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Patrick J. Zenner | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2021 | 11,517 | 55,681 (0%) | 0% | 0 | Common Stock | |
| West Pharmaceutical Servic... | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 790 | 67,508 (0%) | 0% | - | Common Stock | |
| West Pharmaceutical Servic... | Patrick J. Zenner | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2021 | 310 | 67,198 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 136 | 16,894 | - | - | Phantom Stock Unit | |
| West Pharmaceutical Servic... | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 165 | 16,758 | - | - | Phantom Stock Unit | |
| Selecta Biosciences Inc | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges